{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:45:54Z","timestamp":1780872354914,"version":"3.54.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007192","name":"National Institute for Public Health and the Environment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007192","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","cghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cgh.2024.08.041","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T02:36:11Z","timestamp":1728614171000},"page":"653-661.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Harm-to-Benefit Ratio of Fecal Immunochemical Test\u2013Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4001-2949","authenticated-orcid":false,"given":"Esther","family":"Toes-Zoutendijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilliene J.","family":"van de Schootbrugge-Vandermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Katsara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon C.W.","family":"Spaander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke J.","family":"van Vuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert J.","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelien","family":"Dekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris D.","family":"Nagtegaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique E.","family":"van Leerdam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Lansdorp-Vogelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinier G.S.","family":"Meester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2024.08.041_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejca.2022.10.016","article-title":"Advanced-stage CRC incidence patterns following the phased implementation of the CRC screening programme in the Netherlands","volume":"178","author":"Breekveldt","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cgh.2024.08.041_bib2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(21)00199-6","article-title":"Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study","volume":"22","author":"Cardoso","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cgh.2024.08.041_bib3","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMsr1714643","article-title":"The IARC Perspective on Colorectal Cancer Screening","volume":"378","author":"Lauby-Secretan","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2024.08.041_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1177\/09691413221085218","article-title":"Interval cancers in a population-based screening program for colorectal cancer with gender-specific cut-off levels for fecal immunochemical test","volume":"29","author":"Ribbing Wil\u00e9n","year":"2022","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.cgh.2024.08.041_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/bjc.2017.375","article-title":"Risk-adjusted colorectal cancer screening using the FIT and routine screening data: development of a risk prediction model","volume":"118","author":"Cooper","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cgh.2024.08.041_bib6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0969141316653983","article-title":"Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round","volume":"24","author":"Digby","year":"2017","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.cgh.2024.08.041_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/gutjnl-2022-327188","article-title":"Faecal occult blood loss accurately predicts future detection of colorectal cancer. A prognostic model","volume":"72","author":"Meester","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.08.041_bib8","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1002\/ijc.34373","article-title":"Factors Associated With Interval Colorectal Cancer after Negative FIT: Results of Two Screening Rounds in the Dutch FIT-based CRC Screening Program","volume":"152","author":"Breekveldt","year":"2023","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cgh.2024.08.041_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/0969141319879712","article-title":"Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe","volume":"27","author":"Toes-Zoutendijk","year":"2020","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.cgh.2024.08.041_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1053\/j.gastro.2016.11.022","article-title":"Real-time monitoring of results during first year of Dutch colorectal cancer screening program and optimization by altering fecal immunochemical test cut-off levels","volume":"152","author":"Toes-Zoutendijk","year":"2017","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.cgh.2024.08.041_bib12","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2018.294041","article-title":"Quality monitoring of a fit-based colorectal cancer screening program","volume":"65","author":"Toes-Zoutendijk","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.cgh.2024.08.041_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1053\/j.gastro.2014.06.008","article-title":"Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program","volume":"147","author":"Auge","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2024.08.041_bib14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10552-022-01568-9","article-title":"A\u00a0scoping review of risk-stratified bowel screening: current evidence, future directions","volume":"33","author":"Cairns","year":"2022","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.cgh.2024.08.041_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ijc.33784","article-title":"Risk-stratified strategies in population screening for colorectal cancer","volume":"150","author":"Lansdorp-Vogelaar","year":"2022","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cgh.2024.08.041_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12911-019-0812-1","article-title":"Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees","volume":"19","author":"Peng","year":"2019","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.cgh.2024.08.041_bib17","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/gutjnl-2018-318198","article-title":"Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy","volume":"69","author":"Senore","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2024.08.041_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejca.2018.11.004","article-title":"Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program","volume":"107","author":"Buron","year":"2019","journal-title":"Eur J Cancer"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524008784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356524008784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T07:13:59Z","timestamp":1740640439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356524008784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1542356524008784"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2024.08.041","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harm-to-Benefit Ratio of Fecal Immunochemical Test\u2013Based Screening for Colorectal Cancer Given Prior Fecal Hemoglobin Concentrations","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2024.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}